| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP, Chief Scientific Ofc, COO | Chief Operating Officer | Chief Operating Officer
1 company
Jim Wassil is EVP, Chief Scientific Ofc, COO at PCVX. Jim Wassil's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $8.8M at current prices.
Our model assigns Jim Wassil a middling insider score of 53/100, based on 31 past trades. Over a 12-month horizon, 50.0% of those trades were profitable, with an average 12-month return of -9.0%.
The PCVX filings lean toward selling, a net 179,087 shares.
Jim Wassil has 55 Form 4 filings on record from January 2021 to October 2026, all as EVP, Chief Scientific Ofc, COO at Vaxcyte (PCVX), 2021–2026.
The 169 reported transactions were 95 open-market sales, 35 option exercises, 20 tax withholdings and 10 option or other derivative awards, plus smaller numbers of other types.
Counted by filing, the open-market trades come to no purchases and 38 sales worth about $12.9M.
The largest open-market sale was 18,000 shares of PCVX at an average $86.74 on October 5, 2026, about $1.6M.
28 of the 30 sales since April 2023 were made under a Rule 10b5-1 trading plan; the other 2 were not.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 5, 2026 | PCVX Vaxcyte, Inc. | EVP, Chief Scientific Ofc, COO | Sale+OE10b5-1 | 18,000 | $86.74 | $1,561,320.00 | -11.0% | - | - | |
| Oct 1, 2026 | PCVX Vaxcyte, Inc. | EVP, Chief Scientific Ofc, COO | Sale+OE10b5-1 | 2,250 | $56.67 | $127,513.30 | -1.5% | - | - | |
| Sep 9, 2026 | PCVX Vaxcyte, Inc. | EVP, Chief Scientific Ofc, COO | Sell | 2,715 | $60.35 | $163,862.97 | -1.8% | - | - | |
| Sep 1, 2026 | PCVX Vaxcyte, Inc. | Chief Operating Officer | Sale+OE | 3,477 | $61.07 | $212,351.63 | -2.2% | - | - | |
| Aug 3, 2026 | PCVX Vaxcyte, Inc. | Chief Operating Officer | Sale+OE10b5-1 | 2,250 | $53.86 | $121,194.84 | -1.4% | - | - | |
| Jul 1, 2026 | PCVX Vaxcyte, Inc. | Chief Operating Officer | Sale+OE10b5-1 | 2,250 | $56.33 | $126,736.25 | -1.4% | +1.1% | - | |
| Jun 1, 2026 | PCVX Vaxcyte, Inc. | Chief Operating Officer | Sell10b5-1 | 2,250 | $49.52 | $111,415.75 | -1.4% | +24.2% | - | |
| May 1, 2026 | PCVX Vaxcyte, Inc. | Chief Operating Officer | Sell10b5-1 | 2,250 | $56.83 | $127,869.75 | -1.4% | -1.7% | - | |
| Apr 1, 2026 | PCVX Vaxcyte, Inc. | Chief Operating Officer | Sell10b5-1 | 2,250 | $58.43 | $131,475.87 | -1.4% | -0.6% | - | |
| Mar 10, 2026 | PCVX Vaxcyte, Inc. | Chief Operating Officer | Sell10b5-1 | 7,395 | $58.88 | $435,439.81 | -4.2% | -20.4% | - |